We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Deep Learning Advances Imaging Mass Spectrometry with Virtual Histological Detail

By LabMedica International staff writers
Posted on 06 Aug 2025

Imaging mass spectrometry (IMS) is a powerful technique that can map thousands of molecular species in biological tissues with exceptional chemical specificity. More...

However, IMS is hindered by relatively low spatial resolution and a lack of cellular morphological detail—both of which are crucial for accurately interpreting molecular profiles within the structural context of tissue.

Conventional workflows also rely on labor-intensive chemical staining and complex image registration, which consume time and compromise tissue integrity. Now, a novel diffusion-based virtual staining approach can transform low-resolution IMS data into high-resolution histological images, improving the clarity of tissue structure without sacrificing the original sample.

The artificial intelligence (AI)-based technique developed by an international team of researchers from the University of California, Los Angeles (UCLA, Los Angeles, CA, USA), Vanderbilt University (Nashville, TN, USA) and Delft University of Technology (TU Delft, Delft, Netherlands) uses a diffusion-based generative model to virtually stain label-free IMS images. This model digitally produces images that closely resemble traditional histochemical staining—particularly Periodic Acid-Schiff (PAS) staining, which highlights polysaccharides, glycoproteins, and mucins—despite the original IMS data having pixel sizes nearly ten times larger than those of optical microscopy.

By optimizing the noise sampling process during AI inference, the researchers enhanced the reliability and consistency of the virtual staining. The method allows the digital transformation of IMS data into high-resolution brightfield microscopy images, eliminating the need for chemical staining and preserving tissue samples for further molecular analysis.

The research team tested the solution in blind evaluations on human kidney tissues, where the virtually stained images successfully enabled pathologists to identify critical renal structures and disease features with accuracy comparable to conventional stained images. The results, published in Nature Communications, show that the technique significantly improves the interpretability of IMS data and holds potential for widespread clinical and research applications.

By virtually introducing microscopic-level histological detail, the method supports IMS-driven molecular histology while streamlining workflows. The researchers anticipate that their AI-driven approach will open new possibilities in spatial biology and clinical diagnostics and plan to expand its use across other tissue types and staining modalities.

“This diffusion-based approach dramatically enhances the interpretability of mass spectrometry images. It virtually introduces microscopic-level histological detail, bridging the gap between molecular specificity and cellular morphology, all without chemically staining the tissue,” said Professor Aydogan Ozcan, corresponding author at UCLA.

Related Links:
UCLA 
Vanderbilt University
TU Delft


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hematology Analyzer
Medonic M32B
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Industry

view channel
Image: MG Tech adds STOMmics Stereo-seq spatial multi-omics technology to its potfolio (photo courtesy of STOmics)

MGI Tech Strengthens Sequencing Portfolio with Dual Acquisition

MGI Tech Co., Ltd. (Shenzhen, China) announced the acquisition of STOmics and CycloneSEQ on March 3, 2026, as part of its “SEQALL+GLI+Omics” strategy. According to the company, the combined portfolio spans... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.